Inactive Instrument

Highlights Forbion European Acquisition Corp. Nasdaq

Equities

EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.	10-31	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/10/23	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.	16/05/23	CI
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Forbion European Acquisition Corp. has completed an IPO in the amount of $110 million.	09/12/21	CI
Forbion European Acquisition Corp. has filed an IPO in the amount of $100 million.	23/11/21	CI

No results for this search